PHARMULATOR Trademark

Trademark Overview


On Monday, December 7, 2020, a trademark application was filed for PHARMULATOR with the United States Patent and Trademark Office. The USPTO has given the PHARMULATOR trademark a serial number of 79303409. The federal status of this trademark filing is REGISTERED as of Tuesday, January 18, 2022. This trademark is owned by PharmCADD CO., LTD.. The PHARMULATOR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Design and development of virtual reality software; scientific and technological services, namely, scientific research; scientific laboratory services; protein chemical analysis; product development of devices for protein analysis; new product design services, namely, design of devices intended for protein analysis; database design and development; scientific research conducted using databases; biological analysis of molecular anatomy; product development of devices for molecular analysis; development of computer software for big data processing; technical consulting services in the field of data analysis for biotechnological applications; technical consulting services in the field of computer software development for biotechnological applications; research in the field of biotechnology; biochemical analysis; software as a service (SAAS) services featuring software for use in the design and research of pharmaceutical preparations and compounds, used for simulation of molecular dynamics...
pharmulator

General Information


Serial Number79303409
Word MarkPHARMULATOR
Filing DateMonday, December 7, 2020
Status700 - REGISTERED
Status DateTuesday, January 18, 2022
Registration Number6617249
Registration DateTuesday, January 18, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 2, 2021

Trademark Statements


Goods and ServicesDesign and development of virtual reality software; scientific and technological services, namely, scientific research; scientific laboratory services; protein chemical analysis; product development of devices for protein analysis; new product design services, namely, design of devices intended for protein analysis; database design and development; scientific research conducted using databases; biological analysis of molecular anatomy; product development of devices for molecular analysis; development of computer software for big data processing; technical consulting services in the field of data analysis for biotechnological applications; technical consulting services in the field of computer software development for biotechnological applications; research in the field of biotechnology; biochemical analysis; software as a service (SAAS) services featuring software for use in the design and research of pharmaceutical preparations and compounds, used for simulation of molecular dynamics, and for use in quantum calculation in the field of pharmaceuticals and medicines; platform as a service (PAAS) featuring computer software platforms for software for use in the design and research of pharmaceutical preparations and compounds, used for simulation of molecular dynamics, and for use in quantum calculation in the field of pharmaceuticals and medicines; technical support services, namely, providing technical advice in the field of drug discovery for providing artificial intelligence based computer software; drug discovery services; research in the field of pharmacogenetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; technical consultancy relating to pharmaceutical research and development; clinical trials in medicines for others; hosting an online website featuring medical information; design of medical diagnostic apparatus and instruments; computer services, namely, computer system administration for others for remote data management of medical diagnostic instruments; technical support services, namely, troubleshooting of computer software problems in the field of medical diagnostics; research for medical products; technical consulting services in the field of testing, inspection, and research of medical products; research and development of computer software platforms in the field of artificial intelligence; development of computer software for artificial intelligence services; scientific research, namely, conducting clinical trials for others; updating and maintenance of computer software; drug discovery services through a method of computer modeling; rental of computer programs of computer simulation; chemical analysis

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 8, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharmCADD CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NamePharmCADD CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NamePharmCADD CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Monday, July 18, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, June 29, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, June 28, 2022FINAL DISPOSITION PROCESSED
Monday, April 18, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 18, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, December 18, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, November 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, June 20, 2021REFUSAL PROCESSED BY IB
Tuesday, June 1, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 1, 2021REFUSAL PROCESSED BY MPU
Friday, May 28, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 27, 2021NON-FINAL ACTION WRITTEN
Wednesday, May 26, 2021ASSIGNED TO EXAMINER
Friday, February 12, 2021APPLICATION FILING RECEIPT MAILED
Monday, February 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 4, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB